Skip to main content

Table 2 Results of cognitive function and pulmonary function assessment (Mean ± SD)

From: Smoking related attention alteration in chronic obstructive pulmonary disease-smoking comorbidity

Characteristics

COPD-Smoking

(n=20)

COPD-Nonsmoking

(n=22)

NonCOPD-Smoking

(n=22)

NonCOPD-Nonsmoking

(n=21)

Age

68.30 ± 8.12

70.86 ± 7.87

66.45 ± 9.04

70.24 ± 7.62

Education

6.90 ± 4.94

4.73 ± 4.52

6.36 ± 4.01

4.81 ± 3.84

Gender(female/male)

0/20

14/8

0/22

13/8

Attention ability

5.15 ± 1.14

4.32 ± 0.99

5.82 ± 0.50

5.86 ± 0.48

Total score

23.05 ± 3.59

19.73 ± 3.61

26.95 ± 2.40

28.67 ± 2.54

FEV1%

50.30 ± 17.21

54.23 ± 17.08

101.36 ± 9.73

102.95 ± 10.37

FVC%

67.95 ± 16.20

64.05 ± 15.14

90.32 ± 7.23

89.67 ± 6.85

FEV1/FVC

54.30 ± 9.30

58.14 ± 8.16

87.27 ± 5.20

87.00 ± 4.92

COPD history

9.05 ± 7.56

19.36 ± 10.97

None

None

  1. The attention ability was measured by the MoCA scale. FVC FEV1%: forced expiratory volume in one second. FVC%: forced vital capacity